![Lisa A. Michaels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa A. Michaels
No open positions remaining
Profile
Lisa A. Michaels worked as the Head of Rare Disease, Cell & Gene Therapy at Bayer Pharmaceuticals Corp.
She then worked as the Chief Medical Officer & Executive Vice President at Editas Medicine, Inc. from 2020 to 2022.
Michaels holds a doctorate degree from the University of Virginia.
Former positions of Lisa A. Michaels
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 2022-02-06 |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | 2020-10-31 |
Training of Lisa A. Michaels
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bayer Pharmaceuticals Corp. | |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
- Stock Market
- Insiders
- Lisa A. Michaels
